共 137 条
[1]
Harris PA(2008)Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-b enzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor J Med Chem 51 4632-4640
[2]
Boloor A(2012)Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial Lancet 379 1879-1886
[3]
Cheung M(2012)PALETTE: final overall survival (OS) data and predictive factors for OS of EORTC 62072/GSK VEG110727, a randomized double-blind phase III trial of pazopanib versus placebo in advanced soft tissue sarcoma (STS) patients ASCO Meeting Abstracts 30 10009-1068
[4]
Kumar R(2010)Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial J Clin Oncol 28 1061-1296
[5]
Crosby RM(2013)A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update European journal of cancer (Oxford, England : 1990) 49 1287-332
[6]
Davis-Ward RG(2015)Endometrial stromal tumours revisited: an update based on the 2014 WHO classification J Clin Pathol 68 325-683
[7]
Epperly AH(2013)Endometrial stromal sarcoma: a systematic review Obstet Gynecol 122 676-653
[8]
Hinkle KW(2012)The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor Am J Surg Pathol 36 641-757
[9]
Hunter RN(2014)Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement Mod Pathol 27 751-1215
[10]
Johnson JH(2008)Endometrial stromal sarcoma: a population-based analysis Br J Cancer 99 1210-1089